TheEws/Fli-1Fusion Gene Switches the Differentiation Program of Neuroblastomas to Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors
Authors:
Open Access
- 15 February 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (4) , 1266-1277
Abstract
Neuroblastoma (NB) and the Ewing sarcoma (ES)/peripheral primitive neuroectodermal tumor (PNET) family are pediatric cancers derived from neural crest cells. Although NBs display features of the sympathetic nervous system, ES/PNETs express markers consistent with parasympathetic differentiation. To examine the control of these differentiation markers, we generated NB × ES/PNET somatic cell hybrids. NB-specific markers were suppressed in the hybrids, whereas ES/PNET-specific markers were unaffected. These results suggested that the Ews/Fli-1 fusion gene, resulting from a translocation unique to ES/PNETs, might account for the loss of NB-specific markers. To test this hypothesis, we generated two different NB cell lines that stably expressed the Ews/Fli-1 gene. We observed that heterologous expression of the Ews/Fli-1 protein led to the suppression of NB-specific markers and de novo expression of ES/PNET markers. To determine the extent of changes in differentiation, we used the Affymetrix GeneChip Array system to observe global transcriptional changes of genes. This analysis revealed that the gene expression pattern of the Ews/Fli-1-expressing NB cells resembled that observed in pooled ES/PNET cell lines and differed significantly from the NB parental cells. Therefore, we propose that Ews/Fli-1 contributes to the etiology of ES/PNET by subverting the differentiation program of its neural crest precursor cell to a less differentiated and more proliferative state.Keywords
This publication has 73 references indexed in Scilit:
- Suppression of the Ewing’s sarcoma phenotype by FLI1/ERF repressor hybridsCancer Gene Therapy, 2000
- Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic AcidNew England Journal of Medicine, 1999
- Allelic deletion at 11q23 is common in MYCN single copy neuroblastomasOncogene, 1999
- EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenicNature Genetics, 1997
- Molecular basis for heterogeneity in human neuroblastomasEuropean Journal of Cancer, 1995
- Retinoic acid and camp differentially regulate human chromogranin a promoter activity during differentiation of neuroblastoma cellsEuropean Journal of Cancer, 1995
- Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12) and neuroblastomaEuropean Journal of Cancer, 1995
- Biochemical evidence for a mature phenotype in morphologically poorly differentiated neuroblastomas with a favourable outcomeEuropean Journal of Cancer, 1995
- Cytogenetics and experimental models of sarcomasCurrent Opinion in Oncology, 1994
- Multiple DNA-protein interactions at the CpG island of the human pseudoautosomal geneMIC2Somatic Cell and Molecular Genetics, 1993